• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

退行性主动脉瓣狭窄中的组织和血清生物标志物——对发病机制、预防和治疗的见解

Tissue and Serum Biomarkers in Degenerative Aortic Stenosis-Insights into Pathogenesis, Prevention and Therapy.

作者信息

Kapelouzou Alkistis, Geronikolou Styliani, Lidoriki Irene, Kontogiannis Christos, Kaklamanis Loukas, Tsourelis Loukas, Cokkinos Dennis V

机构信息

Center for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, 11527 Athens, Greece.

1st Department of Surgery, School of Medicine, National and Kapodistrian University of Athens, Laiko Hospital, 11527 Athens, Greece.

出版信息

Biology (Basel). 2023 Feb 22;12(3):347. doi: 10.3390/biology12030347.

DOI:10.3390/biology12030347
PMID:36979039
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10045285/
Abstract

BACKGROUND AND AIM

Degenerative Aortic Stenosis (DAS) is a common disease that causes substantial morbidity and mortality worldwide, especially in the older population. Our aim was to further investigate novel serum and tissue biomarkers to elucidate biological processes involved in this entity.

MATERIAL AND METHODS

We evaluated the expression of six biomarkers significantly involved in cardiovascular pathology, i.e., irisin, periostin, osteoglycin, interleukin 18, high mobility group box 1 and proprotein convertase subtilisin/kexin type 9 in the serum at the protein level, and in the tissue at both the protein and mRNA levels of patients with AS (N = 60). Five normal valves obtained after transplantation from hearts of patients with idiopathic dilated cardiomyopathy were also studied. Serum measurements were also performed in 22 individuals without valvular disease who served as controls (C).

RESULTS

Higher levels of all factors were found in DAS patients' serum than in normal C. IHC and PCR mRNA tissue analysis showed the presence of all biomarkers in the aortic valve cusps with DAS, but no trace of PCR mRNA was found in the five transplantation valves. Moreover, periostin serum levels correlated significantly with IHC and mRNA tissue levels in AS patients.

CONCLUSION

We showed that six widely prevalent biomarkers affecting the atherosclerotic process were also involved in DAS, suggesting a strong osteogenic and pro-inflammatory profile, indicating that aortic valve calcification is a multifactorial biological process.

摘要

背景与目的

退行性主动脉瓣狭窄(DAS)是一种常见疾病,在全球范围内导致大量发病和死亡,尤其是在老年人群中。我们的目的是进一步研究新的血清和组织生物标志物,以阐明该疾病所涉及的生物学过程。

材料与方法

我们评估了六种与心血管病理密切相关的生物标志物,即鸢尾素、骨膜蛋白、骨形成蛋白、白细胞介素18、高迁移率族蛋白B1和枯草杆菌蛋白酶/kexin 9型前蛋白转化酶在60例主动脉瓣狭窄(AS)患者血清中的蛋白水平表达,以及在其组织中的蛋白和mRNA水平表达。还研究了从特发性扩张型心肌病患者心脏移植后获得的五个正常瓣膜。对22名无瓣膜疾病的个体进行血清检测,作为对照(C)。

结果

发现DAS患者血清中所有因子的水平均高于正常对照。免疫组化(IHC)和PCR mRNA组织分析显示,DAS患者的主动脉瓣叶中存在所有生物标志物,但在五个移植瓣膜中未发现PCR mRNA痕迹。此外,骨膜蛋白血清水平与AS患者的IHC和mRNA组织水平显著相关。

结论

我们发现六种广泛存在的影响动脉粥样硬化过程的生物标志物也与DAS有关,提示其具有强烈的成骨和促炎特征,表明主动脉瓣钙化是一个多因素的生物学过程。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f36c/10045285/0571907c0c96/biology-12-00347-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f36c/10045285/789c1d522442/biology-12-00347-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f36c/10045285/12bf9697c9c2/biology-12-00347-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f36c/10045285/0571907c0c96/biology-12-00347-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f36c/10045285/789c1d522442/biology-12-00347-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f36c/10045285/12bf9697c9c2/biology-12-00347-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f36c/10045285/0571907c0c96/biology-12-00347-g003.jpg

相似文献

1
Tissue and Serum Biomarkers in Degenerative Aortic Stenosis-Insights into Pathogenesis, Prevention and Therapy.退行性主动脉瓣狭窄中的组织和血清生物标志物——对发病机制、预防和治疗的见解
Biology (Basel). 2023 Feb 22;12(3):347. doi: 10.3390/biology12030347.
2
Serum and Vascular Stiffness Biomarkers Associated with the Severity of Degenerative Aortic Valve Stenosis and Cardiovascular Outcomes.与退行性主动脉瓣狭窄严重程度及心血管结局相关的血清和血管僵硬度生物标志物
J Cardiovasc Dev Dis. 2022 Jun 17;9(6):193. doi: 10.3390/jcdd9060193.
3
Proprotein convertase subtilisin/kexin type 9 levels and aortic valve calcification: A prospective, cross sectional study.前蛋白转化酶枯草杆菌蛋白酶/kexin 9型水平与主动脉瓣钙化:一项前瞻性横断面研究。
J Int Med Res. 2016 Aug;44(4):865-74. doi: 10.1177/0300060516648030. Epub 2016 Jun 8.
4
Differential expression patterns of Toll Like Receptors and Interleukin-37 between calcific aortic and mitral valve cusps in humans.Toll 样受体和白细胞介素-37 在人类钙化主动脉瓣和二尖瓣瓣叶中的差异表达模式。
Cytokine. 2019 Apr;116:150-160. doi: 10.1016/j.cyto.2019.01.009. Epub 2019 Feb 1.
5
Sclerostin as a potential novel biomarker for aortic valve calcification: an in-vivo and ex-vivo study.硬化素作为主动脉瓣钙化潜在的新型生物标志物:一项体内和体外研究。
J Heart Valve Dis. 2013 May;22(3):317-25.
6
Proteomic Biomarkers for Incident Aortic Stenosis Requiring Valvular Replacement.用于需要瓣膜置换的主动脉瓣狭窄事件的蛋白质组学生物标志物。
Circulation. 2018 Aug 7;138(6):590-599. doi: 10.1161/CIRCULATIONAHA.117.030414.
7
PCSK9 R46L Loss-of-Function Mutation Reduces Lipoprotein(a), LDL Cholesterol, and Risk of Aortic Valve Stenosis.PCSK9 R46L功能丧失突变可降低脂蛋白(a)、低密度脂蛋白胆固醇水平及主动脉瓣狭窄风险。
J Clin Endocrinol Metab. 2016 Sep;101(9):3281-7. doi: 10.1210/jc.2016-1206. Epub 2016 May 24.
8
[Histopathologic features of degenerative aortic valve and its mechanisms].[退行性主动脉瓣的组织病理学特征及其机制]
Zhonghua Yi Xue Za Zhi. 2013 Jan 22;93(4):280-4.
9
10
Tissue resident C reactive protein in degenerative aortic valves: correlation with serum C reactive protein concentrations and modification by statins.退行性主动脉瓣中的组织驻留C反应蛋白:与血清C反应蛋白浓度的相关性及他汀类药物的修饰作用
Heart. 2006 Apr;92(4):495-8. doi: 10.1136/hrt.2005.069815. Epub 2005 Sep 13.

引用本文的文献

1
Aortic Stenosis Prevention: Is a New Cardiovascular Disease Paradigm Coming of Age?主动脉瓣狭窄的预防:一种新的心血管疾病范式即将成熟?
J Clin Med. 2025 Jan 29;14(3):903. doi: 10.3390/jcm14030903.
2
Insights into calcific aortic valve stenosis: a comprehensive overview of the disease and advancing treatment strategies.钙化性主动脉瓣狭窄的见解:疾病综述与治疗策略进展
Ann Med Surg (Lond). 2024 Apr 29;86(6):3577-3590. doi: 10.1097/MS9.0000000000002106. eCollection 2024 Jun.
3
Periostin in Osteoporosis and Cardiovascular Disease.

本文引用的文献

1
Effects of PCSK9 Targeting: Alleviating Oxidation, Inflammation, and Atherosclerosis.PCSK9 靶向作用的影响:缓解氧化、炎症和动脉粥样硬化。
J Am Heart Assoc. 2022 Feb;11(3):e023328. doi: 10.1161/JAHA.121.023328. Epub 2022 Jan 20.
2
Associations of pro-protein convertase subtilisin-like kexin type 9, soluble low-density lipoprotein receptor and coronary artery disease: A case-control study.载脂蛋白转化酶枯草溶菌素 9、可溶性低密度脂蛋白受体与冠心病的相关性:病例对照研究。
Int J Cardiol. 2022 Mar 1;350:9-15. doi: 10.1016/j.ijcard.2022.01.014. Epub 2022 Jan 7.
3
Circulating Levels of IL-13, TGF-1, and Periostin as Potential Biomarker for Coronary Artery Disease with Acute Heart Failure.
骨膜蛋白与骨质疏松症和心血管疾病
J Endocr Soc. 2023 Jun 16;7(7):bvad081. doi: 10.1210/jendso/bvad081. eCollection 2023 Jun 5.
4
Translational Aspects of Cardiovascular Biology: From Bench to Bedside.心血管生物学的转化研究:从实验台到病床边
Biology (Basel). 2023 Apr 27;12(5):658. doi: 10.3390/biology12050658.
白细胞介素-13、转化生长因子-1和骨膜蛋白的循环水平作为冠心病伴急性心力衰竭的潜在生物标志物
Evid Based Complement Alternat Med. 2021 Oct 8;2021:1690421. doi: 10.1155/2021/1690421. eCollection 2021.
4
Emergence of SGLT2 Inhibitors as Powerful Antioxidants in Human Diseases.SGLT2抑制剂作为人类疾病中强大抗氧化剂的出现。
Antioxidants (Basel). 2021 Jul 22;10(8):1166. doi: 10.3390/antiox10081166.
5
PCSK9: A Multi-Faceted Protein That Is Involved in Cardiovascular Biology.前蛋白转化酶枯草溶菌素9:一种参与心血管生物学的多功能蛋白质。
Biomedicines. 2021 Jul 8;9(7):793. doi: 10.3390/biomedicines9070793.
6
Empagliflozin Inhibits IL-1β-Mediated Inflammatory Response in Human Proximal Tubular Cells.恩格列净抑制人近端肾小管细胞中 IL-1β 介导的炎症反应。
Int J Mol Sci. 2021 May 11;22(10):5089. doi: 10.3390/ijms22105089.
7
The SGLT2 inhibitor Empagliflozin attenuates interleukin-17A-induced human aortic smooth muscle cell proliferation and migration by targeting TRAF3IP2/ROS/NLRP3/Caspase-1-dependent IL-1β and IL-18 secretion.钠-葡萄糖协同转运蛋白 2 抑制剂恩格列净通过靶向 TRAF3IP2/ROS/NLRP3/Caspase-1 依赖性白细胞介素-1β和白细胞介素-18 的分泌来抑制白细胞介素-17A 诱导的人主动脉平滑肌细胞增殖和迁移。
Cell Signal. 2021 Jan;77:109825. doi: 10.1016/j.cellsig.2020.109825. Epub 2020 Nov 4.
8
Genetic and In Vitro Inhibition of and Calcific Aortic Valve Stenosis.遗传性及体外抑制与钙化性主动脉瓣狭窄
JACC Basic Transl Sci. 2020 Jul 1;5(7):649-661. doi: 10.1016/j.jacbts.2020.05.004. eCollection 2020 Jul.
9
An Exploratory Analysis of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition and Aortic Stenosis in the FOURIER Trial.FOURIER 试验中前蛋白转化酶枯草溶菌素 9 抑制与主动脉瓣狭窄的探索性分析。
JAMA Cardiol. 2020 Jun 1;5(6):709-713. doi: 10.1001/jamacardio.2020.0728.
10
Innate and adaptive immunity in cardiovascular calcification.先天性和适应性免疫在心血管钙化中的作用。
Atherosclerosis. 2020 Aug;306:59-67. doi: 10.1016/j.atherosclerosis.2020.02.016. Epub 2020 Feb 28.